HF
JAGX icon

HRT Financial’s Jaguar Health JAGX Stock Holding History

HRT Financial’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-434
Closed -$5K – 4780
2026
Q1 		$5K Buy
+434
New +$9.51K ﹤0.01% 3665
2025
Q1 		– Sell
-41
Closed -$33K – 2944
2024
Q4 		$33K Buy
+41
New +$35K ﹤0.01% 2152
2024
Q1 		– Hold
0
– -$1K – 2684
2023
Q4 		– Hold
0
– – – 2200
2023
Q2 		– Hold
0
– -$7K – 2859
2023
Q1 		– Hold
0
– – – 2276
2022
Q2 		– Hold
0
– -$12K – 3303
2022
Q1 		– Hold
0
– – – 2885
2021
Q2 		– Hold
0
– -$462K – 3174
2021
Q1 		– Hold
0
– – – 1852
2020
Q4 		– Hold
0
– – – 1748

Other funds holding JAGX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

HRT Financial's JAGX Position: Q2 2026 in Review

HRT Financial sold out of Jaguar Health (JAGX) in Q2 2026, closing a stake of 434 shares — an estimated $5K sold.

HRT Financial first reported a position in JAGX in Q4 2024 and held it in 2 quarters. The position peaked at $33K in Q4 2024. 8 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • HRT Financial reported no remaining Jaguar Health position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 434 Jaguar Health shares in Q2 2026, an estimated $5K.
  • HRT Financial first reported a position in Jaguar Health in Q4 2024 and held it in 2 quarters.
  • HRT Financial's Jaguar Health position peaked at $33K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.